ASND Ascendis Pharma A/S Stock — fundamentals, financials & AI research · AlgoThesis

Stocks›Healthcare›ASND

ASND

Name: AlgoThesis
Author: algothesis

Ascendis Pharma A/S

NasdaqResearch view

Healthcare · Pharmaceutical Preparations · SEC EDGAR FY 2025-12-31

Price history

Interactive · live data via TradingView

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2025-12-31

SectorHealthcare

🔒 Market Cap—

🔒 Enterprise Value—

Income€-228.0M

Sales€720.1M

Book/sh€-2.63

Cash/sh€9.94

🔒 Dividend Est.—

Dividend TTM

Finviz-ordered snapshot — SEC EDGAR fundamentals live; 🔒 cells need a licensed price feed. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

€7.8M

2021

€51.2M

2022

€266.7M

2023

€363.6M

2024

€720.1M

2025

Financials — annual

SEC EDGAR · last 5 FY

EUR	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	€7.8M	€51.2M	€266.7M	€363.6M	€720.1M
Gross Profit	€4.3M	€39.0M	€222.3M	€319.4M	€625.2M
Operating Income	€-451.8M	€-561.8M	€-455.5M	€-278.8M	€-136.3M

Deep dive

Computed from the SEC EDGAR multi-year statements

Operating leverage — margins

GrossOperatingNet

COMMUNITY · $ASND0 theses

POST YOUR TAKE →

Related Stocks

Loading peers…

Ask AI about ASND Build basket with ASND Screener

Fundamentals sourced from SEC EDGAR filings (public domain). For informational purposes only. Not investment advice.